Bonferoni, M.C.; Rassu, G.; Gavini, E.; Sorrenti, M.; Catenacci, L.; Giunchedi, P.
Nose-to-Brain Delivery of Antioxidants as a Potential Tool for the Therapy of Neurological Diseases. Pharmaceutics 2020, 12, 1246.
https://doi.org/10.3390/pharmaceutics12121246
AMA Style
Bonferoni MC, Rassu G, Gavini E, Sorrenti M, Catenacci L, Giunchedi P.
Nose-to-Brain Delivery of Antioxidants as a Potential Tool for the Therapy of Neurological Diseases. Pharmaceutics. 2020; 12(12):1246.
https://doi.org/10.3390/pharmaceutics12121246
Chicago/Turabian Style
Bonferoni, Maria Cristina, Giovanna Rassu, Elisabetta Gavini, Milena Sorrenti, Laura Catenacci, and Paolo Giunchedi.
2020. "Nose-to-Brain Delivery of Antioxidants as a Potential Tool for the Therapy of Neurological Diseases" Pharmaceutics 12, no. 12: 1246.
https://doi.org/10.3390/pharmaceutics12121246
APA Style
Bonferoni, M. C., Rassu, G., Gavini, E., Sorrenti, M., Catenacci, L., & Giunchedi, P.
(2020). Nose-to-Brain Delivery of Antioxidants as a Potential Tool for the Therapy of Neurological Diseases. Pharmaceutics, 12(12), 1246.
https://doi.org/10.3390/pharmaceutics12121246